A prospective investigation of serum bile acids with risk of liver cancer, fatal liver disease, and biliary tract cancer-Reference-Cited by-同舟云学术

A prospective investigation of serum bile acids with risk of liver cancer, fatal liver disease, and biliary tract cancer

Published:2022-06-08 Issue:9 Volume:6 Page:2391-2399
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatology Communications

Author:

Farhat Zeinab¹,Freedman Neal D.¹,Sampson Joshua N.²,Falk Roni T.¹,Koshiol Jill³,Weinstein Stephanie J.¹,Albanes Demetrius¹,Sinha Rashmi¹,Loftfield Erikka¹

Affiliation:

1. Metabolic Epidemiology Branch Division of Cancer Epidemiology and Genetics National Cancer Institute National Institutes of Health Rockville Maryland USA

2. Biostatistics Branch Division of Cancer Epidemiology and Genetics National Cancer Institute National Institutes of Health Rockville Maryland USA

3. Infections and Immunoepidemiology Branch Division of Cancer Epidemiology and Genetics National Cancer Institute National Institutes of Health Rockville Maryland USA

Funder

National Cancer Institute

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.2003

Reference46 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

3. Hepatocellular carcinoma in cirrhosis: Incidence and risk factors